Cancer Clinical Trial
Official title:
TOGETHER: Track Outcomes and Guidance, Technology for Health and Effective Resources
| Verified date | August 2023 |
| Source | Stanford University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The goal of this project is to iteratively develop and test a TOGETHER pilot mobile app product in preparation for commercialization. TOGETHER is a mobile application on a smart software system that informal caregivers can use to develop and implement home-based care for cancer patients/survivors. The Technical Objectives are to: 1. Establish the project team and obtain stakeholder feedback on what to include in the product. 2. Evaluate IT customization requirements and HIPAA compliance security, and privacy protocols. 3. Develop a prototype to show NCI and then a pilot version for beta and usability testing among stakeholders. 4. Enhance interoperability and test integration into health system(s) - if feasible. 5. Develop user support documentation for stakeholders.
| Status | Completed |
| Enrollment | 14 |
| Est. completion date | June 25, 2022 |
| Est. primary completion date | July 21, 2021 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Adults (aged 18 years or older) who are either: - Cancer patient/survivor receiving care or with plans to transition to care in the community setting. - Caregiver of cancer patient/survivor receiving care or with plans to transition to care in the community setting. - Clinician of cancer patient/survivor receiving care or with plans to transition to care in the community setting. - Cancer patient is a patient of Stanford Health Care. - Patient, Caregiver, and Clinician are willing to be connected on the app. - Have a smartphone and data plan that allows for app installation and usage. - Must speak, read and write in English, because all study materials and communication will be in English. Exclusion Criteria: - Patient does not have a cancer diagnosis. - Cancer patient/survivor is not receiving care or does not have plans to transition to care in the community setting. - Cancer patient is not a patient of Stanford Health Care. - Patient, Caregiver, and Clinician are not willing to be connected on the app. - Unable to speak, read and write in English. - Does not have a smartphone nor data plan that allows for app installation and usage |
| Country | Name | City | State |
|---|---|---|---|
| United States | Stanford University | Stanford | California |
| Lead Sponsor | Collaborator |
|---|---|
| Stanford University | Medable Inc., National Institutes of Health (NIH) |
United States,
Oakley-Girvan I, Davis SW, Kurian A, Rosas LG, Daniels J, Palesh OG, Mesia RJ, Kamal AH, Longmire M, Divi V. Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study. JMIR Form Res. 2021 Aug 13;5(8):e226 — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Assess user experience with TOGETHER app | User experiences will be assessed by measuring overall experiences. | 1 year | |
| Primary | Assess user experience with TOGETHER app | User experiences will be assessed by measuring module recommendation. | 1 year | |
| Primary | Assess user experience with TOGETHER app | User experiences will be assessed by measuring dynamics/flow of app use, module recommendation, and general demographics. | 1 year | |
| Primary | Assess user experience with TOGETHER app | User experiences will be assessed by measuring problems with app use. | 1 year | |
| Primary | Assess caregiver's experience with TOGETHER app | Caregiver's experience with TOGETHER app will be assessed for clarity of documentation. | 1 year | |
| Primary | User documentation feedback | General feedback/recommendations for the app, including user documentation feedback. | 1 year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|